Early Asset Development and Commercialization: Partnering for Success

Sponsored by: Cello Health

Jim Hall, President, Cello Health, BioConsulting

Thursday - November 17, 2016 / 10:00am ET
Free Event

To be successful in developing a pharmaceutical asset you have to identify the need and define the commercial value early on in the development process, as well as revisiting and refining the value as you progress through the various phases of development. This means understanding what else is coming onto the market from a competitive perspective and the clinical relevance from a patient perspective. Being mindful about value throughout development process is also important because, at each phase more investment will be needed, especially in smaller companies. Often times the need for investment results in a licensing agreement or a partnership.

In this webinar, Cello Health will discuss the background and context of early asset development and then outline a process that can be followed for finding a partner.

About the Sponsors

Cello Health delivers cutting-edge professional medical and marketing services to the global pharmaceutical, biotechnology and health sectors. Cello Health consists of three distinct capabilities to deliver a fusion of expertise to unlock the potential of organizations, brands and assets:
Cello Health Insight: global marketing research and customer insight
Cello Health BioConsulting: strategic consultancy
Cello Health Communications: evidence and engagement

For more information please visit www.cellohealth.com.

Comments are closed.